blinatumomab
amgen,astellas
['blinatumomab']
#blinatumomab significantly improves os in newly diagnosed b-all patients who are mrd negative after initial treatment #ash22 via 
Evidence-Based #Oncology. Bringing together perspectives of 20,000+ cancer care #providers, #payers, #policymakers, #patients, and researchers in #cancer care.